CIRCULATING ADHESION MOLECULES DURING KIDNEY ALLOGRAFT REJECTION
- 1 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 59 (12) , 1695-1699
- https://doi.org/10.1097/00007890-199506270-00009
Abstract
Adhesion molecules appear on leukocytes and endothelial cells mediating the localization and migration of leukocytes to sites of inflammation. Rejecting kidney grafts have shown an increased expression of these molecules. Recent reports have detected in serum soluble forms of adhesion molecules that could play a role in regulating inflammation. We have measured by ELISA the circulating serum levels of ICAM-1, VCAM-1 and E-selectin in: 23 controls, 33 chronic renal failure patients (CRF), 20 hemodialysis patients (HD), 17 samples from 6 patients with stable kidney graft function (STx), 25 samples from 8 patients with steroid-responsive rejection proven by biopsy, and 28 samples from 9 patients with steroid-resistant rejection and good response to OKT3. There was not a rise in cICAM-1 or cE-selectin levels during rejection compared with the steady phase before and after rejection. In the case of cVCAM-1, only the OKT3 group showed increased rejection levels (PKeywords
This publication has 0 references indexed in Scilit: